5.0 based on 2 reviewsView this provider's reviews
Patient satisfaction ratings and reviews are based on personal opinions. Before you choose any doctor you should take into account their background, training, specialized experience AND their patient satisfaction to ensure they are the right fit for you.
Michael Atkins, MD is Deputy Director of the Georgetown Lombardi Comprehensive Cancer Center and the School Professor and Vice Chair of the Department of Medical Oncology at Georgetown University Medical Center. He is an internationally recognized expert in the management of patients with high risk and metastatic melanoma. Dr. Atkins directs the Melanoma Center at MedStar Washington Hospital Center and leads the Melanoma Research Program within the MedStar Georgetown Cancer Network, which has multiple active cutting edge clinical trials underway for patients with advanced melanoma. He is also a world expert in treatment of patients with advanced kidney cancer having led the Kidney Cancer Program at the Dana Farber Harvard Cancer Center from 2002–2012 and one of the leading authorities in cancer immunotherapy having been a founding member of the Cytokine Working Group and past President of the Society for Immunotherapy of Cancer. Dr. Atkins previously led the Cutaneous Oncology Program at the Beth Israel Deaconess Medical Center and the Melanoma Research Program at the Dana Farber Harvard Cancer Center, both in Boston. He edits the Melanoma Section for Uptodate and is Co-editor of the 5th Edition of the Cutaneous Melanoma textbook. Dr. Atkins is also the author and/or edits the melanoma, kidney cancer and immunotherapy chapters for Uptodate the CDROM based medical textbook. He serves on the Board of the Directors of the Melanoma Research Foundation, is a Member of the Nominating Committee for the American Society of Clinical Oncology and is a past President of the Society for Immunotherapy of Cancer.